A Strategic Approach to Malaria
On December 8, the CSIS Global Health Policy Center hosts a major day-long conference on the future of global malaria efforts. It opens with a high-level deliberation over the strategic long-term goal of elimination, highlighting the political, financial, and institutional requisites. It features expert roundtables on drug and insecticide resistance, future technologies (vaccines, therapies, diagnostics), and financing.
There is a special focus on civilian-military cooperation in the Mekong Subregion. On that day, CSIS releases five commissioned policy analyses.
Conference Agenda:
8:45am-9:00am Welcome remarks
Video: Dr. Margaret Chan, Director-General, WHO
Dr. J. Stephen Morrison, Senior Vice President and Director, CSIS Global Health Policy Center
9:00-10:15 Roundtable: Future Vision for Global Action on Malaria
Dr. Alan Magill, Director, Malaria, Bill & Melinda Gates Foundation
Dr. Bernard Nahlen, Deputy Coordinator, President’s Malaria Initiative
Dr. David J. Smith, Deputy Assistant Secretary of Defense, Force Health Protection and Readiness
Moderator: Dr. J. Stephen Morrison, Senior Vice President and Director, CSIS Global Health Policy Center
10:15-11:15 Panel: Financing of a Global Elimination Strategy
Dr. Jen Kates, Director of Global Health & HIV Policy, Kaiser Family Foundation
Dr. Mead Over, Senior Fellow, Center for Global Development
Mr. Todd Summers, Senior Adviser, CSIS Global Health Policy Center
Moderator: Ms. Amy Studdart, Deputy Director and Fellow, William E. Simon Chair in Political Economy
11:15-12:00 Break
12:00-1:30 Luncheon: Civilian-Military Cooperation in the Mekong Subregion
RADM Colin Chinn, Command Surgeon, U.S. Pacific Command
Dr. Mark Fukuda, CDC Malaria Advisor, President’s Malaria Initiative Greater Mekong Subregion
Maj General Vu Quoc Binh, Director General, Military Medical Department, Vietnam People’s Army
Dr. Nipon Chinanonwait, Director, Thai Bureau of Vector Borne Diseases
Dr. Aung Thi, Director, Myanmar National Malaria Control Programme
Moderator: Dr. Alan Magill, Director, Malaria, Bill & Melinda Gates Foundation
1:30-2:30 Panel: Evolving Technologies in the Push for Elimination
Dr. Ashley Birkett, Director, PATH Malaria Vaccine Initiative
Dr. Christopher Plowe, Professor, University of Maryland School of Medicine
Mr. Paul LaBarre, Senior Technical Officer, PATH
Moderator: Dr. Regina Rabinovich, Exxon Mobil Scholar in Residence, Harvard School of Public Health
2:30-3:30 Panel: The Threat of Artemisinin and Pyrethroid Resistance
Dr. Pascal Ringwald, Coordinator, WHO Drug Resistance and Containment Unit
Dr. Fredros Okumu, Research Scientist, Ifkara Health Institute
Dr. Martin Akogbeto, Director, Centre de Recherché Entomologique de Cotonou (CREC)
Dr. Christopher Plowe, Professor, University of Maryland School of Medicine
Moderator: Dr. S. Patrick Kachur, Chief, CDC Malaria Branch
